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Changing hemodialysis thresholds for optimal survival. Numerous studies have demonstrated an association
Background. The urea reduction ratio (URR), a measure between the amount of hemodialysis and mortality among
quantitating solute removal during hemodialysis, is the frac- patients with end-stage renal disease (ESRD) [1–8]. Intional reduction of the blood urea concentration during a single
general, patient mortality is higher when the hemodialy-hemodialysis treatment. The URR is the principal measure of
sis “dose” is low and is lower when the hemodialysishemodialysis dose in the United States. Based on studies of
patients dialyzed prior to 1994, a minimum URR value of 65% dose is high. The urea reduction ratio (URR) is a com-
was recommended to optimize survival. Because of new hemo- monly used measure of hemodialysis dose and is based
dialysis technologies and evolving demographics of the hemo- on the fractional reduction of blood urea nitrogendialysis population, the relationship between the amount of
(BUN) concentration during a single hemodialysis treat-hemodialysis and mortality was examined in contemporary
cohorts. ment. It is calculated by dividing the fall of BUN (predial-
Methods. This retrospective cohort included .15,000 patients ysis minus postdialysis BUN) by the predialysis and is
per year receiving hemodialysis during 1994 through 1997. Each expressed as a percentage [1, 9–11]. Retrospective stud-
patient’s URR was averaged for the three months prior to the
ies of mortality for ESRD patients suggest that the oddsbeginning of each year. Mortality odds ratios were calculated
of death increase progressively as the URR falls belowfor patients by URR. To determine the URR value above
which no further improvement in mortality was seen (“thresh- 60 to 65% [1–3]. Such findings and a professional consen-
old”), spline functions were tested in logistic regression models, sus have led three national organizations, including the
both unadjusted and adjusted for case mix measures. The Health Care Financing Administration (HCFA), thestrength of fit for URR, defined by a range of candidate thresh-
principal payer of dialysis services, to advocate a URRolds from 55 to 75%, was evaluated in increments of 1% for
of 65% as the threshold for “adequate” hemodialysiseach year using spline functions.
Results. The median URR was 63.2, 65.4, 67.4, and 68.1% and to profile providers accordingly [9, 10, 12–14].
for 1994 through 1997, respectively. The median length of hemo- Using URR as a measure of hemodialysis dose, substan-
dialysis treatments increased only six minutes from the begin-
tial improvement in the amount of hemodialysis has oc-ning to the end of the period of analysis. Using spline functions,
curred in recent years. As reported in the 1998 Nationalthe threshold URR values were 61.1, 65.0, 68.0, and 71.0% for
1994 through 1997 in models adjusted for case mix. The ratio ESRD Core Indicators Report, a profile of patient-
of median URR to URR threshold decreased from 1.03 in specific dialysis practices, the mean URR for the United
1994 to 0.97 in 1997. States increased from 62.7% (deemed inadequate) toConclusions. From 1994 to 1997, the median URR and the
68.0% (deemed adequate) from 1993 to 1997 [14]. Al-URR threshold for mortality benefit increased. Although an
though mean URR provides a gauge of hemodialysisincreased need in the amount of hemodialysis may be a conse-
quence of changes in patients’ demographic characteristics, the adequacy at the population level, the proportion of pa-
likely explanation(s) is a change in the dialysis procedure and/or tients whose URR is $65% is of greater significance for
blood sampling favoring higher URR values without changing
optimizing individual patient survival. Using this clinicalthe amount of dialysis provided. The recommended minimum
performance benchmark, the percentage of patients re-URR of 65% appears to be too low to confer an optimal mortal-
ity benefit in the context of current practices. ceiving a URR $65% rose from 43% in 1993 to 72%
in 1997 [14].
The aforementioned outcome studies characterizingKey words: end-stage renal disease, dialysis outcome, Medicare, urea
reduction ratio, adequate hemodialysis. the association between the amount of hemodialysis and
patient mortality utilized data sets from before 1994Received for publication February 3, 2000
[1–8]. However, the applicability of these studies mayand in revised form June 13, 2000
Accepted for publication August 11, 2000 be limited because of evolving demographics of the he-
modialysis population and the diffusion of newer hemo-Ó 2001 by the International Society of Nephrology
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dialysis technologies. For example, the prevalent hemo- ables, when a single analytic description, formula, or func-
dialysis population includes more patients who are older, tion is not valid over the entire range of values. Spline
who have diabetes mellitus, and who are racial and ethnic functions transform these relationships into small seg-
minorities [15]. Additionally, prevalent hemodialysis prac- ments of relatively simple functions connected at junc-
tices have changed with the increased use of bicarbonate- ture points or “knots.” Initially, two-segment splines were
buffered dialysis solutions, high-flux and biocompatible used to describe the relationship between threshold
dialysis membranes, and reprocessed dialyzers [14]. The URR and mortality odds. To identify a threshold, this
effects of these demographic changes and the diffusion analysis assumes that the relationship between URR and
of newer technologies on the relationship between the mortality has two discrete segments. The first segment
amount of hemodialysis and mortality have not been eval- demonstrates an inverse relationship between URR and
uated. This study was undertaken to examine the validity
mortality. This inverse relationship continues to a thresh-
of the previously demonstrated relationship between
old value of URR, which marks the beginning of the sec-amount of hemodialysis and mortality in the setting of
ond segment, above which no further mortality benefitthese secular trends.
is observed despite an increasing URR. To assess which
URR value defined the spline with the best fit, URR was
METHODS transformed using each candidate URR threshold by
Data were taken from the routine analytical files of this equation:
Fresenius Medical Care-North America, Inc. (FMC,
Lexington, MA, USA) for the calendar years 1994 (URR 2 t)1 5 50, URR ^ tURR 2 t, URR , tthrough 1997 [1, 5]. The final sample was comprised of
all patients receiving three times weekly hemodialysis
where the (URR 2 t)1 term evaluates the differencewho were prevalent on January 1 of each year and either
between the measured URR and the candidate thresholdlived the entire year on dialysis or died. Dropouts were
(t, from 55 to 75% in 1% increments) for all URR lessnot included in the sample studied. The URR for each
than each candidate threshold. The “1” subscript indi-patient was calculated by 100 3 (predialysis BUN 2
cates that the term has been truncated during the trans-postdialysis BUN) 4 predialysis BUN. Prior to the re-
formation process performed in this analysis. All URRlease of the National Kidney Foundation’s Dialysis Out-
values $t were assigned a value of 0.comes Quality Initiative on Hemodialysis Adequacy in
For each year, separate logistic regression models esti-1997, no specific protocol was specified for the sampling
mated the association between mortality and (URR 2 t)1of blood for the measurement of postdialysis BUN. Fre-
using each of the 21 candidate threshold URR valuessenius endorsed a minimum URR or Kt/V of 65% (URR)
[19]. This association was modeled in both a univariateor 1.2 [Kt/V (single pool)], respectively, but this was not
mandated. The URR and serum albumin concentrations and multivariable manner. For each year, the strength
for the last three months of each prior year were aver- of the association between URR and mortality using
aged. All measurements were determined in a single each candidate threshold was estimated in separate logis-
laboratory (LifeChem Clinical Laboratories, Rockleigh, tic regression models, unadjusted and adjusted for case
NJ, USA). Only patients with complete demographic mix. The strength of fit for the association between mor-
and laboratory data were included in the cohorts. tality and URR as described by each threshold URR
The patients’ demographic and clinical features were was evaluated using the x2 statistic associated with the
compared using the x2 test and the x2 test for trend across (URR 2 t)1 term. The larger the x2 statistic associated
years. For patients with a URR ,60%, the odds ratios with the spline for each threshold URR, the greater the
for mortality were calculated in URR increments of 5%; amount of variation in outcome explained by URR using
for patients with a URR $60%, the URR increments
that specific threshold. The x2 statistic for URR as de-
were 2.5%, and patients whose URR was .80% com-
scribed by each candidate threshold was plotted againstprised the reference group. Odds ratios were calculated
the threshold for each year. This analysis was repeatedin univariate and multivariable analyses, the latter con-
using Kt/V transformed from URR by taking the nega-trolled for age, gender, race, and diabetes mellitus (case
tive loge of one minus the URR divided by 100 [11, 20].mix variables). Risk curves of URR versus log trans-
The routine analytical files of FMC for calendar yearsformed odds ratios were plotted for each year.
1994 through 1997 do not contain data on the intradia-To describe the relationship between URR and mor-
lytic ultrafiltration volume.tality odds, spline functions were used [16, 17], as they
All P values are two-sided, and confidence intervalshave been used in prior analyses of dialysis adequacy
are 95%. Analyses were performed using SAS (versionand mortality [2, 18]. Spline functions mathematically
describe complex relationships between continuous vari- 6.08; SAS Institute Inc., Cary, NC, USA).
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Table 1. Description of final patient cohorts
1994 1995 1996 1997
Characteristic N517,141 N520,785 N515,155 N515,197
Age years
Mean 60.0614.8 60.2615.0 59.5614.9 59.9614.9
Median 62.3 62.5 62.0 62.0
Female % 49.3 49.1 49.9 50.0
Caucasian race % 49.7 46.1 46.9 50.0
Diabetes mellitusa % 39.1 42.4 44.9 47.2
Height cm
Mean 168.0610.8 167.7611.0 165.6612.3 165.5612.8
Median 167.6 167.6 165.0 165.0
Weight kg
Mean 70.9617.9 70.9618.1 71.5618.2 72.0618.4
Median 68.5 68.3 69.0 69.3
Wt/Ht kg/cm
Mean 0.4260.10 0.4260.10 0.4360.10 0.4460.11
Median 0.41 0.41 0.41 0.42
Albumin g/dL
Mean 3.8160.42 3.8560.37 3.9060.38 3.8560.38
Median 3.83 3.87 3.93 3.88
Dialysis length hours
Meana 3.3860.48 3.3760.49 3.4360.46 3.4860.47
Median 3.50 3.50 3.46 3.46
URR %
Meana 62.2968.2 65.167.8 66.767.3 67.367.5
Median 63.2 65.4 67.4 68.1
Vintage years
Mean (SD) n/a 3.763.8 3.763.6 3.563.6
Median n/a 2.5 2.5 2.4
Plus-minus values are means 6 SD; diabetes mellitus describes the presence of diabetes mellitus as a diagnosis or a comorbid condition; vintage refers to the
number of years since starting dialysis; serum albumin concentrations were drawn predialysis.
a P , 0.0001 for values 1994 to 1997
RESULTS of URR candidate thresholds. Figure 2 plots each URR
threshold and the associated x2 statistic for the case mixThe patients’ demographic features, anthropometric
adjusted model. The larger the x2 statistic, the strongerattributes, and distribution of selected laboratory tests
the association between the individual threshold URRare provided in Table 1. Their mean and median ages
value and mortality. For each year, the curves increasedand composition by gender and race were stable from
as a smooth, monotonic function to a peak and subse-1994 to 1997. Also, anthropometric attributes, described
quently decreased in a similar manner. The URR thresh-by height, weight, and weight/height ratio, were stable.
old values with the largest x2 statistic were 61, 65, 68,However, the proportion of patients with diabetes melli-
and 71% for 1994, 1995, 1996, and 1997, respectively.tus rose over the period of observation from 39.1% in
For the unadjusted analyses, threshold URR values were1994 to 47.2% in 1997 (P , 0.0001). The mean URR
60, 64, 66, and 69%, respectively, for the same years.increased during the period of observation from 62.9%
These findings suggest an increase in apparent thresholdin 1994 to 67.3% in 1997 (P , 0.0001). The average
for hemodialysis adequacy during this period. In addi-length of hemodialysis treatments increased only six min-
tional analyses, patients with and without diabetes melli-utes (P , 0.0001). The serum albumin concentration was
tus were evaluated separately. For each year, the plotsstable from 1994 to 1997.
of URR threshold values and their associated x2 statisticThe association between log odds ratios for mortality
revealed no consistent differences between diabetics andand URR adjusted for age, race, gender, and diabetes
nondiabetics (data not shown).mellitus for each year is presented in Figure 1. During
To assess the effect of different modeled relationshipseach year, as the URR increased, the log odds for mortal-
between URR and mortality on the increasing thresholdity decreased. The odds of death declined to an apparent
for adequacy in dialysis dose, complimentary analysesURR threshold, above which increasing URR values did
were performed using two- and three-segment splines.not reduce death risk further. A similar relationship was
One model assumes that the reduction in death riskrevealed in the absence of adjustment for case mix mea-
declines to a nadir, and any additional increase in URRsures. To quantitatively evaluate the perception that the
above this threshold results in a higher mortality (V-URR threshold increased from 1994 to 1997, spline func-
tions were fit in logistic regression models using the range shaped relationship). The second model assumes a re-
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Fig. 1. Risk curves for urea reduction ratio
(URR) and odds ratio of mortality. The loga-
rithm of odds ratio for mortality is plotted
against URR stratified by year.
verse J-shaped relationship. The initial decline is sepa- 1994, the URR threshold has increased more than the
median URR. This secular trend suggests that improve-rated from the terminal increase in mortality odds by
interposing a flat middle segment, during which no ments in mortality may have not been realized fully.
These analyses assume that the relationship betweenchange is seen with increasing URR. Using either as-
sumption, the threshold URR values for each year were URR and mortality has two discrete segments. The first
segment has an inverse relationship of decreasing mortal-unchanged from the results obtained with two-segment
spline analyses (data not shown). ity with increasing URR, until a threshold URR value
is achieved, which marks the beginning of the secondThe relationship between the median URR and URR
threshold by year is illustrated in Figure 3. Both measure- segment above which no further mortality benefit is ob-
tained. Such a relationship has been described by severalments increased from 1994 through 1997. However, the
ratio of the median URR to threshold URR decreased investigators [1, 3, 5, 22, 23]. Alternative models were
derived based on descriptions suggesting that the rela-from 1.03 in 1994 to 0.97 in 1997. The slope of this
relationship indicates that the URR threshold increased tionship between URR and mortality may be V or reverse
J shaped [2, 3, 24]. The URR threshold values were notfaster than the median URR.
changed by modeling using these different assumptions.This analysis was repeated using Kt/V extrapolated
The increment in URR threshold values was associ-from URR as the measurement of dialysis dose. A similar
ated temporally with an increase in median URR values.increase in threshold dose was demonstrated over the
Hypotheses to explain the changing relationship be-period of observation (data not shown).
tween hemodialysis dose and mortality include temporal
changes in patient demographics, the hemodialysis pro-
DISCUSSION cedure, and/or prevalent blood sampling techniques. For
The URR remains the preponderant measure of dial- example, if dissimilar demographic groups have differen-
ysis dose in the United States [14]. This retrospective tial needs for hemodialysis [4, 5], a change in the case
study of large cohorts of hemodialysis patients demon- mix of prevalent patients may result in an increased
strates that the conventional minimum URR of 65%, proportion of patients with a need for increased hemodi-
recommended to minimize death risk [9, 10, 12–14], may alysis. Some have posited that patients with diabetes
be too low for current hemodialysis practice. The thresh- mellitus require greater doses of hemodialysis to achieve
old for the 1994 data set of patients was 61%. Assuming similar survival [4]. While the proportion of patients with
variability of 2.4% for a URR determination [21], a mini- diabetes mellitus in the sample increased between 1994
mum URR of 65% was adequate. However, by 1997, and 1997, the URR thresholds for patients with and
the threshold URR value had increased to 71%. This without diabetes mellitus increased over time and were
discordance between the URR value associated with op- not different by diabetic status. Furthermore, the pre-
timal mortality benefit (“threshold”), and the conven- ponderance of evidence fails to support a need for in-
tional benchmark of 65% suggests that some patients creased hemodialysis for patients with diabetes mellitus
[1, 2, 5].may be placed at excessive death risk. Moreover, since
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Fig. 2. Strength of association between URR
and mortality. The x2 statistic for each candi-
date URR threshold in the logistic regression
model of mortality is plotted against the candi-
date URR threshold stratified by year.
nutrition and/or inflammation, changed from 1994 to
1997 [1, 5, 23, 27, 28].
Another putative explanation to account for the in-
creased dialysis dose thresholds is that the URR does
not measure the removal of the critical uremic toxin. A
small body of recent evidence suggests that URR does
not account for the removal of all toxins associated with
mortality, such as larger molecular weight solutes [29].
Therefore, a higher URR would be needed to achieve
removal of these toxins. This putative mechanism also
seems unlikely because hemodialyzer technology and the
type of dialyzer used have evolved. Prevalent hemodia-
lyzers have better solute removal profiles for large molec-
ular weight solutes [14]. If the composition of the cohort
Fig. 3. Temporal trends for the prevalent median URR (x-axis) plotted with significant residual renal function remained the
against URR threshold (y-axis) values. same during each year, this would introduce another
source of variance into the association between dialysis
dose and mortality biasing our ability to determine a
difference between years toward the null. Alternatively,Nutrition is a major mortality predictor for ESRD
if the composition of the cohort with significant residualpatients, statistically more powerful than the amount of
renal function decreased in number with each advancinghemodialysis [1, 4, 5, 24]. Recent data suggest that pa-
year, the association between dialysis dose and mortalitytients’ anthropometric attributes (weight, body surface
may be affected shifting the curves to the right. However,area, and body mass index) and the volume of urea
as residual renal function declines with increasing timedistribution (total body water) may be surrogate markers
since the initiation of dialysis, the use of only prevalentfor nutritional status among ESRD patients. Higher
patients minimizes the potential impact of this limitation.measurements are associated with improved survival [5,
Supporting our ability to compare the cohorts is that the18, 23, 25]. Lower anthropometric attributes result in a
length of time since initiation of dialysis (vintage) hadsmaller urea distribution volume and typically greater
not changed for the years 1995 through 1997.amounts of dialysis [5, 26] but are paradoxically associ-
A systematic change in the dialysis technique and/orated with higher death risks [23]. It is unlikely that the
in the timing for drawing blood samples for the URRfindings herein are explained by a trend toward decreas-
could also account for these observations. Although theing anthropometric measures among dialysis patients.
rate of transfer of urea between intracellular and extra-Neither the cohorts’ anthropometric attributes nor their
serum albumin concentrations, a laboratory surrogate of cellular water is rapid, inequality in urea concentration
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may develop between the two compartments during a stimulus for more focused monitoring, profiles, and
investigations by the regional peer review organizations,rapid hemodialysis. When this occurs, urea that has been
effectively sequestered intracellularly diffuses back into corporate dialysis providers, and individual dialysis units.
In the context of substantial pressure to improve dial-the extracellular compartment (“urea rebound”). This
process begins immediately at the end of hemodialysis ysis doses, it is noteworthy that two 1995 surveys of
greater than 200 hemodialysis centers in the Unitedand lasts over 30 minutes. Therefore, as blood is sampled
over the minutes after the end of hemodialysis, the post- States and Canada reported over 20 different methods
for sampling blood to measure postdialysis BUN [37, 38].dialysis BUN will rapidly increase, and the calculated
URR becomes smaller. The converse is also true. The As mentioned earlier, a trend toward the use of more
efficient dialyzers has occurred that would favor in-closer the postdialysis BUN is drawn to the end of dial-
ysis, the lower its value and the higher the calculated creased urea rebound [29]. This change in dialyzer type
superimposed on wide variability in methods for sam-URR. By not accounting for the sequestered amount
of urea, the URR becomes less reflective of total urea pling postdialysis BUN could result in higher prevalent
URR values. Moreover, higher URR values achieved inremoval [10]. Secular changes in the hemodialysis tech-
nique, such as the reported increase in the use of higher this or another manner would be welcome by the dialysis
community as evidence of betterment. However, in thisflux dialysis membranes that result in increased dialysis
efficiency [14], may cause more urea rebound. If the situation, the URR would be accompanied by a rise in
the threshold for hemodialysis adequacy. If we assumeuse of higher flux membranes is associated with greater
rebound, measured URR would be higher, but the that these findings are the consequence of variability in
postdialysis BUN sampling, this is the first longitudinalamount of hemodialysis delivered would be relatively
little changed. Mortality relationships would shift toward analysis to examine the potential quantitative effect of
this variability on patient mortality.higher URR values. Higher URR values would compen-
sate for an overestimation of total urea removal. An Recent evidence has suggested that K 3 t is a valid
outcome-based measure of hemodialysis dose that is lessalternative, but less frequently used measure of hemodi-
alysis dose, Kt/V, is based on pharmacokinetic theory influenced by anthropometric attributes, which have out-
come-associated properties of their own [5, 25]. Amongand attempts to normalize the dose of hemodialysis for
the urea distribution volume [10]. It is unclear whether a patient cohort receiving hemodialysis during 1994, their
mortality risk profile improved until K 3 t was 41.2 tothe use of Kt/V, instead of URR as the predominant
measure of hemodialysis dose, will minimize the appar- 47.3 L per treatment in men and 37.0 to 41.2 L per
treatment in women [25]. There were no additional im-ent need for higher dialysis doses by its improved kinetic
accuracy. This issue may be clarified by the findings from provements in mortality risk for either group as K 3 t
increased above these values. Analysis of a patient co-the National Institute of Diabetes, Digestive, and Kidney
Diseases Hemodialysis Study, which is based on equili- hort receiving dialysis during 1998 demonstrated that a
K 3 t of at least 50 L per treatment was required tobrated Kt/V measurements and will be available within
the next two years [30]. Moreover, the randomized, con- achieve maximal death risk reduction [39]. This compari-
son suggests that regardless of the measure of dialysistrolled study design will minimize biases inherent to ret-
rospective studies. dose, an increasing standard for dialysis adequacy re-
mains evident. Moreover, it underscores that the mea-Finally, substantial pressure has been exerted to im-
prove dialysis outcomes by increasing the amount of surement of dialysis dose rather than the method of
calculation have evolved.hemodialysis [31–34]. Both URR and Kt/V are calcu-
lated centrally by Fresenius’ laboratory services; the ag- The same is true for dialysis dose calculated as Kt/V.
We acknowledge that the transformation formula usedgregate results are reviewed centrally and facility and
patient-specific results reviewed and acted upon locally in this analysis does not account for convective solute
clearance [11], so it is not surprising that the relationshipwithin individual dialysis units. For example, a highly
publicized national discussion proposed linking dialysis between Kt/V and URR thresholds is similar. However,
this computational limitation does not compromise thefacility reimbursement to the quality of hemodialysis
services measured using URR [35]. In 1993, a longitudi- relevance of the findings. First, URR remains the princi-
pal measure of dialysis dose in the United States [14],nal, nationwide cohort study revealed that only 43% of
the patients had a URR $65% [14]. There resulted an so the findings reported herein are germane to the pre-
ponderance of clinical dialysis practices. Second, withinurgency to improve URR values without explicit instruc-
tion regarding strategies to achieve this goal. Recogniz- the FMC system from which the data is derived, and
throughout the United States, few practitioners converting an opportunity and need to improve patient out-
comes, HCFA restructured its method for national URR to Kt/V. Thus, their clinical behavior is driven by
the results reported from URR, rather than the Kt/V.quality improvement in 1994 [14, 36]. Although this was
a population-based initiative, it was intended to serve as Third, to date, there is no peer-reviewed literature that
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